pyrazolanthrone has been researched along with Disease Exacerbation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, F; Jing, Y; Liu, D; Lv, W; Xin, T | 1 |
| Banerjee, D; Banerjee, S; Ghosh, M; Lahiry, L; Roy, A | 1 |
| Gao, P; Hou, B; Li, H; Li, L; Liu, D; Sun, D; Wei, Y; Zeng, W; Zhang, C; Zhang, N; Zhang, Z | 1 |
| Bedja, D; Chen, Y; Cohn, RD; Dietz, HC; Doyle, JJ; Habashi, JP; Holm, TM; Judge, DP; Kim, D; Lindsay, ME; Loeys, BL; Marugan, JJ; Patnaik, S; Schoenhoff, F; Thomas, CJ; van Erp, C | 1 |
| Bilter, GK; Boluro-Ajayi, M; Ennis, BW; Fultz, KE; Smith, KA; Stein, B; Westwick, JK; Zhu, D | 1 |
5 other study(ies) available for pyrazolanthrone and Disease Exacerbation
| Article | Year |
|---|---|
ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
Topics: A549 Cells; Anthracenes; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Disease Progression; Gene Knockdown Techniques; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; MAP Kinase Signaling System; Mitochondria; Mitochondrial Dynamics; Protein Serine-Threonine Kinases; rho-Associated Kinases; RNA, Small Interfering; Tumor Suppressor Proteins | 2020 |
Increased cytoplasmic localization of p27(kip1) and its modulation of RhoA activity during progression of chronic myeloid leukemia.
Topics: Anthracenes; Antigens, CD34; Apoptosis; Blast Crisis; Cyclin-Dependent Kinase Inhibitor p27; Cytoplasm; Disease Progression; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Guanosine Triphosphate; Humans; K562 Cells; Leukemia, Myeloid, Chronic-Phase; Lymphocytes; MAP Kinase Kinase 4; Phosphorylation; Primary Cell Culture; Protein Kinase Inhibitors; rhoA GTP-Binding Protein; Signal Transduction | 2013 |
Synergistic effects of c-Jun and SP1 in the promotion of TGFβ1-mediated diabetic nephropathy progression.
Topics: Adult; Aged; Animals; Anthracenes; Blotting, Western; Cell Line; Diabetic Nephropathies; Disease Progression; Female; Glucose; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mesangial Cells; Mice, Inbred C57BL; Microscopy, Fluorescence; Middle Aged; Mutation; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-jun; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sp1 Transcription Factor; Transforming Growth Factor beta1 | 2016 |
Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice.
Topics: Animals; Anthracenes; Aorta; Aortic Aneurysm; Diphenylamine; Disease Models, Animal; Disease Progression; Enzyme Activation; Losartan; MAP Kinase Signaling System; Marfan Syndrome; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Protein Kinase Inhibitors; Smad2 Protein; Smad4 Protein; Sulfonamides; Transforming Growth Factor beta | 2011 |
Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Endothelial Cells; Female; Flow Cytometry; G2 Phase; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms | 2005 |